Pacira BioSciences (PCRX) Exchange Rate Effect (2025 - 2026)

Pacira BioSciences' (PCRX) quarterly Exchange Rate Effect came in at $38000.0 in Q1 2026, up 109.18% quarter-over-quarter from -$414000.0 in Q4 2025.

Pacira BioSciences (PCRX) Exchange Rate Effect (2025 - 2026) Analysis & Trends

Pacira BioSciences' Exchange Rate Effect history runs 2 years deep, the most recent figure standing at $38000.0 for Q1 2026.

On a quarterly basis, Exchange Rate Effect changed N/A year-over-year to $38000.0 in Q1 2026; TTM through Mar 2026 was -$39000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$77000.0, changed N/A from the prior year.
Exchange Rate Effect grew to $38000.0 in Q1 2026 per PCRX's latest filing, from -$414000.0 in the prior quarter.
Across five years, Exchange Rate Effect topped out at $204000.0 in Q2 2025 and bottomed at -$414000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-17.00 Mn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	17.00 Mn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	7.01 Mn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-4.20 Mn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-5.00 Mn
10	Pacira BioSciences	1.05 Bn	846.97 Mn	140.96 Mn	38,000.00

Download Data